America’s biopharmaceutical companies are committed to developing solutions to help diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus.
LATEST ARTICLES
-
This Scientist Is Working to Develop a Potential COVID-19 Vaccine
Janssen is one among dozens of biopharmaceutical companies working around the clock to identify and develop safe and effective vaccines to prevent COVID-19.
-
By the Numbers: Vaccines and Treatments in Development for COVID-19
America's biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19.
RELATED ARTICLES
The Incredible Power of Immunization
In 1796, the trajectory of our relationship with disease changed permanently when Edward Jenner invented the first vaccine.
The Next Threat: Combatting Antimicrobial Resistance
After decades of helping to lower the mortality rate from pneumonia, tuberculosis and other types of infection, the medicines we rely on now face the growing threat of antimicrobial resistance.
How Intellectual Property Protections Spur Innovation
Strong IP protections are critical to safeguarding innovation within the biopharmaceutical industry.
Progress Against Infectious Diseases: Where Do We Stand?
Over the years, treatments for infectious diseases have grown steadily more complex, and today, our ability to respond to diseases like COVID-19 is radically different than it would have been even a few decades ago.
Fighting Back Against the Coronavirus
As people across the globe continue to be impacted by COVID-19, the disease caused by a new strain of coronavirus, biopharmaceutical companies have rapidly taken action to research and develop potential new medicines, while partnering with public health leaders worldwide, to combat this global public health emergency.
